Year |
Citation |
Score |
2020 |
Lagisetty P, Eeda V, Yadav VR, Nimmo SL, Subramaniam D, Powell DR, Awasthi V. Tumor suppressive activities of solvatochromic 3,3'-azadimethylene dinaphthospiropyran in colon cancer model. Chemical Biology & Drug Design. PMID 32909340 DOI: 10.1111/Cbdd.13785 |
0.378 |
|
2019 |
Awasthi V, Vilekar P, Rao G, Awasthi S. Anti-inflammatory mediators ST2 and SIGIRR are induced by diphenyldifluoroketone EF24 in lipopolysaccharide-stimulated dendritic cells. Immunobiology. PMID 31812341 DOI: 10.1016/J.Imbio.2019.11.021 |
0.778 |
|
2019 |
Yari H, Nkepang G, Awasthi V. Surface Modification of Liposomes by a Lipopolymer Targeting Prostate Specific Membrane Antigen for Theranostic Delivery in Prostate Cancer. Materials (Basel, Switzerland). 12. PMID 30841602 DOI: 10.3390/Ma12050756 |
0.308 |
|
2018 |
Rao G, Nkepang G, Xu J, Yari H, Houson H, Teng C, Awasthi V. Ubiquitin Receptor RPN13 Mediates the Inhibitory Interaction of Diphenyldihaloketones CLEFMA and EF24 With the 26S Proteasome. Frontiers in Chemistry. 6: 392. PMID 30280096 DOI: 10.3389/Fchem.2018.00392 |
0.322 |
|
2016 |
Yadav VR, Rao G, Houson H, Hedrick A, Awasthi S, Roberts PR, Awasthi V. Nanovesicular Liposome-Encapsulated Hemoglobin (LEH) Prevents Multi-organ Injuries in a Rat Model of Hemorrhagic Shock. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. PMID 27503458 DOI: 10.1016/J.Ejps.2016.08.010 |
0.32 |
|
2016 |
Rao G, Yadav VR, Awasthi S, Roberts PR, Awasthi V. Effect of liposome-encapsulated hemoglobin resuscitation on proteostasis in small intestinal epithelium after hemorrhagic shock. American Journal of Physiology. Gastrointestinal and Liver Physiology. ajpgi.00157.2016. PMID 27288424 DOI: 10.1152/Ajpgi.00157.2016 |
0.307 |
|
2015 |
Vilekar P, Rao G, Awasthi S, Awasthi V. Diphenyldifluoroketone EF24 Suppresses Pro-inflammatory Interleukin-1 receptor 1 and Toll-like Receptor 4 in lipopolysaccharide-stimulated dendritic cells. Journal of Inflammation (London, England). 12: 55. PMID 26401121 DOI: 10.1186/S12950-015-0096-X |
0.759 |
|
2015 |
Rao G, Xie J, Hedrick A, Awasthi V. Hemorrhagic shock-induced cerebral bioenergetic imbalance is corrected by pharmacologic treatment with EF24 in a rat model. Neuropharmacology. PMID 26232641 DOI: 10.1016/J.Neuropharm.2015.07.033 |
0.315 |
|
2015 |
Rao G, Hedrick AF, Yadav VR, Xie J, Hussain A, Awasthi V. The brain metabolic activity after resuscitation with liposome-encapsulated hemoglobin in a rat model of hypovolemic shock. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 25944591 DOI: 10.1038/Jcbfm.2015.82 |
0.307 |
|
2015 |
Jackson KW, Christiansen VJ, Yadav VR, Silasi-Mansat R, Lupu F, Awasthi V, Zhang RR, McKee PA. Suppression of tumor growth in mice by rationally designed pseudopeptide inhibitors of fibroblast activation protein and prolyl oligopeptidase. Neoplasia (New York, N.Y.). 17: 43-54. PMID 25622898 DOI: 10.1016/J.Neo.2014.11.002 |
0.356 |
|
2014 |
Yadav VR, Hussain A, Sahoo K, Awasthi V. Remediation of hemorrhagic shock-induced intestinal barrier dysfunction by treatment with diphenyldihaloketones EF24 and CLEFMA. The Journal of Pharmacology and Experimental Therapeutics. 351: 413-22. PMID 25204337 DOI: 10.1124/Jpet.114.217331 |
0.72 |
|
2014 |
Yadav VR, Vilekar P, Awasthi S, Awasthi V. Hemorrhage-induced interleukin-1 receptor pathway in lung is suppressed by 3,5-bis(2-fluorobenzylidene)-4-piperidone in a rat model of hypovolemic shock Artificial Organs. 38: 675-683. PMID 24749913 DOI: 10.1111/Aor.12305 |
0.773 |
|
2014 |
Yadav VR, Nag O, Awasthi V. Biological evaluation of liposome-encapsulated hemoglobin surface-modified with a novel PEGylated nonphospholipid amphiphile. Artificial Organs. 38: 625-33. PMID 24749870 DOI: 10.1111/Aor.12304 |
0.307 |
|
2014 |
Vilekar P, King C, Lagisetty P, Awasthi V, Awasthi S. Antibacterial activity of synthetic curcumin derivatives: 3,5-bis(benzylidene)-4-piperidone (EF24) and EF24-dimer linked via diethylenetriaminepentacetic acid (EF2DTPA). Applied Biochemistry and Biotechnology. 172: 3363-73. PMID 24532443 DOI: 10.1007/S12010-014-0741-5 |
0.764 |
|
2013 |
Yadav VR, Sahoo K, Awasthi V. Preclinical evaluation of 4-[3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl]-4-oxo-2-butenoic acid, in a mouse model of lung cancer xenograft. British Journal of Pharmacology. 170: 1436-48. PMID 24102070 DOI: 10.1111/Bph.12406 |
0.738 |
|
2013 |
Yadav VR, Sahoo K, Roberts PR, Awasthi V. Pharmacologic suppression of inflammation by a diphenyldifluoroketone, EF24, in a rat model of fixed-volume hemorrhage improves survival. The Journal of Pharmacology and Experimental Therapeutics. 347: 346-56. PMID 23995597 DOI: 10.1124/Jpet.113.208009 |
0.748 |
|
2013 |
Aravindan S, Natarajan M, Awasthi V, Herman TS, Aravindan N. Novel synthetic monoketone transmute radiation-triggered NFκB-dependent TNFα cross-signaling feedback maintained NFκB and favors neuroblastoma regression. Plos One. 8: e72464. PMID 23967300 DOI: 10.1371/Journal.Pone.0072464 |
0.334 |
|
2013 |
Pathuri G, Hedrick AF, Awasthi V, Ihnat MA, Gali H. Evaluation of 99mTc-probestin for imaging APN expressing tumors by SPECT. Bioorganic & Medicinal Chemistry Letters. 23: 5049-52. PMID 23937983 DOI: 10.1016/J.Bmcl.2013.07.046 |
0.309 |
|
2013 |
Nag OK, Yadav VR, Hedrick A, Awasthi V. Post-modification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexadecanoic acid for enhanced circulation persistence in vivo. International Journal of Pharmaceutics. 446: 119-29. PMID 23419666 DOI: 10.1016/J.Ijpharm.2013.02.026 |
0.332 |
|
2013 |
Yadav VR, Sahoo K, Awasthi V. Abstract 4866: CLEFMA induces apoptosis and downregulates inflammatory markers in lung cancer model. Cancer Research. 73: 4866-4866. DOI: 10.1158/1538-7445.Am2013-4866 |
0.766 |
|
2013 |
Sahoo KK, Yadav VR, Awasthi V. Abstract 3286: CLEFMA synergizes with celecoxib in suppression of lung cancer cell growth. Cancer Research. 73: 3286-3286. DOI: 10.1158/1538-7445.Am2013-3286 |
0.759 |
|
2013 |
Lagisetty P, Agashe H, Awasthi V. 2-[3,5-Bis-(2-fluorobenzylidene)-4-piperidon-1-yl]-N-(4-fluorobenzyl)-acetamide and Its Evaluation as an Anticancer Agent Journal of Chemistry. 2013: 935646. DOI: 10.1155/2013/935646 |
0.365 |
|
2012 |
Pathuri G, Hedrick AF, Disch BC, Ihnat MA, Awasthi V, Gali H. Synthesis and biodistribution studies of technetium-99m-labeled aminopeptidase N inhibitor conjugates. Bioorganic & Medicinal Chemistry Letters. 22: 4567-70. PMID 22727671 DOI: 10.1016/J.Bmcl.2012.05.106 |
0.322 |
|
2012 |
Vilekar P, Awasthi S, Natarajan A, Anant S, Awasthi V. EF24 suppresses maturation and inflammatory response in dendritic cells. International Immunology. 24: 455-64. PMID 22378503 DOI: 10.1093/Intimm/Dxr121 |
0.773 |
|
2012 |
Pathuri G, Hedrick AF, Disch BC, Doan JT, Ihnat MA, Awasthi V, Gali H. Synthesis and evaluation of novel Tc-99m labeled probestin conjugates for imaging APN/CD13 expression in vivo. Bioconjugate Chemistry. 23: 115-24. PMID 22148582 DOI: 10.1021/Bc200546B |
0.334 |
|
2012 |
Lagisetty P, Subramaniam D, Sahoo K, Anant S, Awasthi V. Anticancer activity of an imageable curcuminoid 1-[2-aminoethyl-(6-hydrazinopyridine-3-carbamidyl)-3,5-bis-(2-fluorobenzylidene)-4-piperidone (EFAH). Chemical Biology & Drug Design. 79: 194-201. PMID 22107757 DOI: 10.1111/J.1747-0285.2011.01271.X |
0.735 |
|
2012 |
Sahoo K, Dozmorov MG, Anant S, Awasthi V. The curcuminoid CLEFMA selectively induces cell death in H441 lung adenocarcinoma cells via oxidative stress. Investigational New Drugs. 30: 558-67. PMID 21181232 DOI: 10.1007/S10637-010-9610-4 |
0.752 |
|
2012 |
Sahoo KK, Yadav VR, Awasthi V. Abstract 4887: Curcuminoid CLEFMA induces autophagy-associated apoptosis in lung cancer Cancer Research. 72: 4887-4887. DOI: 10.1158/1538-7445.Am2012-4887 |
0.755 |
|
2012 |
Yadav VR, Sahoo KK, Awasthi V. Abstract 256: Involvement of ERK and ROS in CLEFMA-induced apoptosis in lung cancer cells Cancer Research. 72: 256-256. DOI: 10.1158/1538-7445.Am2012-256 |
0.753 |
|
2011 |
Subramaniam D, Nicholes ND, Dhar A, Umar S, Awasthi V, Welch DR, Jensen RA, Anant S. 3,5-bis(2,4-difluorobenzylidene)-4-piperidone, a novel compound that affects pancreatic cancer growth and angiogenesis. Molecular Cancer Therapeutics. 10: 2146-56. PMID 21890747 DOI: 10.1158/1535-7163.Mct-11-0399 |
0.376 |
|
2011 |
Pathuri G, Sahoo K, Awasthi V, Gali H. Renogram comparison of p-[(18)F]fluorohippurate with o-[(125)I]iodohippurate and [(99m)Tc]MAG3 in normal rats. Nuclear Medicine Communications. 32: 908-12. PMID 21876402 DOI: 10.1097/Mnm.0B013E32834A6Db6 |
0.7 |
|
2011 |
Agashe H, Lagisetty P, Sahoo K, Bourne D, Grady B, Awasthi V. Liposome-encapsulated EF24-HPβCD inclusion complex: a preformulation study and biodistribution in a rat model. Journal of Nanoparticle Research : An Interdisciplinary Forum For Nanoscale Science and Technology. 13: 2609-2623. PMID 21779150 DOI: 10.1007/S11051-010-0154-5 |
0.737 |
|
2011 |
Veeraraghavan J, Natarajan M, Lagisetty P, Awasthi V, Herman TS, Aravindan N. Impact of curcumin, raspberry extract, and neem leaf extract on rel protein-regulated cell death/radiosensitization in pancreatic cancer cells. Pancreas. 40: 1107-19. PMID 21697760 DOI: 10.1097/Mpa.0B013E31821F677D |
0.347 |
|
2011 |
Agashe H, Sahoo K, Lagisetty P, Awasthi V. Cyclodextrin-mediated entrapment of curcuminoid 4-[3,5-bis(2-chlorobenzylidene-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid] or CLEFMA in liposomes for treatment of xenograft lung tumor in rats. Colloids and Surfaces. B, Biointerfaces. 84: 329-37. PMID 21315563 DOI: 10.1016/J.Colsurfb.2011.01.023 |
0.757 |
|
2011 |
Awasthi S, Brown K, King C, Awasthi V, Bondugula R. A toll-like receptor-4-interacting surfactant protein-A-derived peptide suppresses tumor necrosis factor-α release from mouse JAWS II dendritic cells. The Journal of Pharmacology and Experimental Therapeutics. 336: 672-81. PMID 21159752 DOI: 10.1124/Jpet.110.173765 |
0.315 |
|
2011 |
Subramaniam D, Awasthi V, Houchen CW, Jensen RA, Anant S. Abstract 5417: A novel curcumin derivative DiFiD prevents pancreatic cancer growthin vivoby suppressing Notch-1 Cancer Research. 71: 5417-5417. DOI: 10.1158/1538-7445.Am2011-5417 |
0.399 |
|
2011 |
Veeraraghavan J, Natarajan M, Awasthi V, Herman TS, Aravindan N. Abstract 4203: EF24, a novel curcumin analogue inhibits oncogenic activation induced by radiation abscopal effect in distant mice lungs Cancer Research. 71: 4203-4203. DOI: 10.1158/1538-7445.Am2011-4203 |
0.357 |
|
2011 |
Veeraraghavan J, Aravindan S, Natarajan M, Awasthi V, Herman TS, Aravindan N. Abstract 2500: Radiosensitizing effects of neem leaf extract in human neuroblastoma xenograft is through modulation of apoptotic pathway Cancer Research. 71: 2500-2500. DOI: 10.1158/1538-7445.Am2011-2500 |
0.377 |
|
2010 |
Vilekar P, Awasthi V, Lagisetty P, King C, Shankar N, Awasthi S. In vivo trafficking and immunostimulatory potential of an intranasally-administered primary dendritic cell-based vaccine. Bmc Immunology. 11: 60. PMID 21143974 DOI: 10.1186/1471-2172-11-60 |
0.763 |
|
2010 |
Pathuri G, Sahoo K, Awasthi V, Gali H. Synthesis and in vivo evaluation of Tc-99m-labeled cyclic CisoDGRC peptide conjugates for targeting αvβ3 integrin expression. Bioorganic & Medicinal Chemistry Letters. 20: 5969-72. PMID 20829039 DOI: 10.1016/J.Bmcl.2010.08.082 |
0.714 |
|
2010 |
Lagisetty P, Vilekar P, Sahoo K, Anant S, Awasthi V. CLEFMA-an anti-proliferative curcuminoid from structure-activity relationship studies on 3,5-bis(benzylidene)-4-piperidones. Bioorganic & Medicinal Chemistry. 18: 6109-20. PMID 20638855 DOI: 10.1016/J.Bmc.2010.06.055 |
0.761 |
|
2010 |
Madhusoodhanan R, Natarajan M, Singh JV, Jamgade A, Awasthi V, Anant S, Herman TS, Aravindan N. Effect of black raspberry extract in inhibiting NFkappa B dependent radioprotection in human breast cancer cells. Nutrition and Cancer. 62: 93-104. PMID 20043264 DOI: 10.1080/01635580903191494 |
0.373 |
|
2010 |
Agashe H, Lagisetty P, Awasthi S, Awasthi V. Improved formulation of liposome-encapsulated hemoglobin with an anionic non-phospholipid. Colloids and Surfaces. B, Biointerfaces. 75: 573-83. PMID 19896346 DOI: 10.1016/J.Colsurfb.2009.09.038 |
0.336 |
|
2010 |
Madhusoodhanan R, Veeraraghavan J, Natarajan M, Herman TS, Awasthi V, Aravindan N. Abstract 5547: EF24 attenuates radiation-regulated eNOS→NO-dependent NFκB-mediated matrix metalloproteinases in human neuroblastoma Cancer Research. 70: 5547-5547. DOI: 10.1158/1538-7445.Am10-5547 |
0.389 |
|
2010 |
Subramaniam D, Nicholes N, May R, Lightfoot SA, Ramanujam RP, Awasthi V, Houchen CW, Anant S. Abstract 5046: SR1264, a novel tetrafluoro analog of curcumin prevents pancreatic tumor growthin vivoby suppressing Notch signaling pathway Cancer Research. 70: 5046-5046. DOI: 10.1158/1538-7445.Am10-5046 |
0.392 |
|
2010 |
Jayaraj R, Piedrafita D, Dynon K, Grams R, Spithill TW, Smooker PM, Ruiz S, Pascal N, Dalencon F, Danve B, Burdin N, Rokbi B, Zahedifard F, Rafati S, Bolhassani A, ... ... Awasthi V, et al. Vaccination and immunotherapy against bacteria, fungi and parasites (WS-048) Chairpersons: Hajime Hisaeda, Miodrag Colic International Immunology. 22. DOI: 10.1093/Intimm/Dxq312 |
0.728 |
|
2010 |
Lagisetty P, Agashe H, Sahoo K, Awasthi V. Tc-99m-labeled novel antiproliferative curcuminoid Nuclear Medicine and Biology. 37: 720-721. DOI: 10.1016/J.Nucmedbio.2010.04.095 |
0.697 |
|
2009 |
Lagisetty P, Vilekar P, Awasthi V. Synthesis of radiolabeled cytarabine conjugates. Bioorganic & Medicinal Chemistry Letters. 19: 4764-7. PMID 19574048 DOI: 10.1016/J.Bmcl.2009.06.056 |
0.763 |
|
2009 |
Ramalingam S, Natarajan G, May R, Lightfoot SA, Awasthi V, Houchen CW, Anant S. S1997 Overexpression of Proto-Oncogene RBM3 Induces Potent Tumor Formation By Converting Normal Cells to Cancer Stem Cells Gastroenterology. 136: A-309-A-310. DOI: 10.1016/S0016-5085(09)61413-X |
0.334 |
|
2005 |
Awasthi S, Awasthi V, Magee DM, Coalson JJ. Efficacy of antigen 2/proline-rich antigen cDNA-transfected dendritic cells in immunization of mice against Coccidioides posadasii. Journal of Immunology (Baltimore, Md. : 1950). 175: 3900-6. PMID 16148136 DOI: 10.4049/Jimmunol.175.6.3900 |
0.319 |
|
2005 |
Awasthi V. Uptake of Radioiodinated Hepatocyte Growth Factor by Lung Adenocarcinoma Cells Clinical Nuclear Medicine. 30: 205. DOI: 10.1097/00003072-200503000-00018 |
0.309 |
|
2003 |
Awasthi V, Goins B, McManus L, Klipper R, Phillipsa WT. [99mTc] liposomes for localizing experimental colitis in a rabbit model. Nuclear Medicine and Biology. 30: 159-68. PMID 12623115 DOI: 10.1016/S0969-8051(02)00419-5 |
0.31 |
|
2001 |
Awasthi S, Vivekananda J, Awasthi V, Smith D, King RJ. CTP:phosphocholine cytidylyltransferase inhibition by ceramide via PKC-alpha, p38 MAPK, cPLA2, and 5-lipoxygenase. American Journal of Physiology. Lung Cellular and Molecular Physiology. 281: L108-18. PMID 11404253 DOI: 10.1152/Ajplung.2001.281.1.L108 |
0.35 |
|
Show low-probability matches. |